I think it's interesting that CCXI had an interesting "side effect" on improved kidney function. There is such a great need for a 21st century lupus nephritis treatment. I always have believed, that if AUPH was going to be able to fire on all cylinders, analysts were way too conservative with their price objectives. This morning's heavy volume and busting the $7.00 barrier is really a sight to behold.
March 1st 2017, over 4 M shares traded, SP went up and a NR was released in the evening after market close confirming AURA achieved primary endpoint at 48 weeks.
I have a feeling that history will repeat itself TODAY with results after market close